Moreover, our data suggested that LV-SIRT1 inhibited hepatic malonyl-CoA accumulation in the HFD-induced NAFLD mice (Fig. 5E,F). Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.